Market Cap
$19.2M
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$4.17 ▲ +5.57%
Prev close $3.95Market cap$19.2M
High Impact Filing (8/10) Biotech & Drug Discovery
Snapshot
The big-picture read on SHPH right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
3 funds
Inst. Value
$81.8K
Inst. Activity
2 buys / 0 sells
Insider Activity
$181.8K buy / $504.8K sell
Insider Net $
-$323.1K
Social Sentiment
75° Bullish
SEC Reports
7
Price chart 30d +19.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 listing_status
Sep 1, 2026 SEC Listing Status: SHPH — Normal (was Delinquent)
Shuttle Pharmaceuticals Holdings, Inc. - common stock | Nasdaq Financial Status Indicator E → N
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) amended its merger agreement with United Dogecoin Inc., reducing the Miles
8-K — Impact 2/10
Jul 14, 2026 Insider
Jul 13, 2026 SEC HRT FINANCIAL LP sold 82,116 shares
10%+ Owner @ $4.48 ($367.9K)
HRT Financial LP filed a Form 3 initial statement of beneficial ownership, disclosing direct ownership of 60,540 shares
3 — Impact 2/10
Jul 13, 2026 Insider
HRT FINANCIAL LP sold 1,033 shares
10%+ Owner @ $4.67 ($4.8K)
Jul 10, 2026 Insider
Jul 1, 2026 SEC HRT FINANCIAL LP bought 731 shares
10%+ Owner @ $3.11 ($2.3K)
HRT Financial LP filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 71,842 shares of Shutt
3 — Impact 2/10
Dec 31, 2025 Inst.
UBS Group AG — DOUBLED
11,947 shares ($21.5K)
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
75°
Bullish
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 0 bullish, 2 bearish, 0 mixed, 5 neutral · avg impact 4.0/10.
NEUTRAL8-K2/10
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) amended its merger agreement with United Dogecoin Inc.
Sep 1, 2026
NEUTRAL32/10
HRT Financial LP filed a Form 3 initial statement of beneficial ownership, disclosing direct ownersh
Jul 13, 2026
NEUTRAL32/10
HRT Financial LP filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 71
Jul 1, 2026
NEUTRAL8-K3/10
Shuttle Pharmaceuticals filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of
Jun 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 29, 2026
listing_status
Listing Status: SHPH — Normal (was Delinquent)
Shuttle Pharmaceuticals Holdings, Inc. - common stock | Nasdaq Financial Status Indicator E → N
Sep 5, 2026
listing_status
Listing Status: SHPH — Delinquent (was Normal)
Shuttle Pharmaceuticals Holdings, Inc. - common stock | Nasdaq Financial Status Indicator N → E
Aug 5, 2026
short_volume
Short Volume: SHPH — 57.2% short (0.3M / 0.5M)
Short: 311,983 | Exempt: 1,916 | TRF Vol: 545,144 | Short Ratio: 57.2% | Off-exchange volume (dark pool + OTC)
Jul 31, 2026
short_volume
Short Volume: SHPH — 59.0% short (1.1M / 1.9M)
Short: 1,132,411 | Exempt: 2,828 | TRF Vol: 1,919,196 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
Jul 15, 2026
ftd
FTD: SHPH — 180,123 shares ($0.7M) failed to deliver
Settlement: 20260715, Price: $4.16, FTD Value: $749,311.68, SHUTTLE PHARMACEUTICALS HLDGS
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own SHPH (from quarterly 13F filings) and who is adding or trimming.
3 institutional holders with $81.8K total value (103,701 shares) as of 2026-Q2. Top holders: CITADEL, BARCLAYS, HRT.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 24,354 | $79.2K | 96.7% | — |
| BARCLAYS PLC | 750 | $2.4K | 3.0% | — |
| HRT FINANCIAL LP | 78,597 | $255.00 | 0.3% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| UBS Group AG | DOUBLED | 8 | 11,947 | +149237.5% | $21.5K |
| BANK OF AMERICA CORP /DE/ | ADD | 8 | 12 | +50.0% | $22.00 |
| UBS Group AG | NEAR_EXIT | 3,367 | 8 | -99.8% | $28.00 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 3 | 8 | +166.7% | $28.00 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
1 insiders, 11 transactions. Net -$323.1K — $181.8K bought, $504.8K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 82,116 | $4.48 | $367.9K |
| Jul 13, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 1,033 | $4.67 | $4.8K |
| Jul 10, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 731 | $3.11 | $2.3K |
| Jul 9, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 8,266 | $3.38 | $27.9K |
| Jul 8, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 18,531 | $3.52 | $65.2K |
| Jul 7, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 10,580 | $3.33 | $35.2K |
| Jul 6, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 9,022 | $3.51 | $31.7K |
| Jul 2, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 7,851 | $3.54 | $27.8K |
| Jul 1, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 3,959 | $3.30 | $13.1K |
| Jun 30, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 6,755 | $3.23 | $21.8K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SHPH.
Shares short
21,975
Settlement Sep 15, 2026
Change vs prior
-44.1%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈2.1%
Estimate — not % of float
All SHPH filing & press-release reports (7)
- 8-K reportSep 1, 2026
- 3 reportJul 13, 2026
- 3 reportJul 1, 2026
- 8-K reportJun 11, 2026
- 8-K reportMay 7, 2026
- 8-K reportMay 1, 2026
- 8-K reportMar 10, 2026